Pharmakon (Biological Product) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 2

Pharmakon (Biological Product) General Information

Description

Provider of medical marketing services. The company offers strategic design, meetings and tactical execution, technology support and lead management services.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Other Healthcare Services
Corporate Office
  • 475 Martingale Road
  • Suite 200
  • Schaumburg, IL 60173
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pharmakon (Biological Product) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Pharmakon (Biological Product)‘s full profile, request access.

Request a free trial

Pharmakon (Biological Product) Executive Team (1)

Name Title Board Seat Contact Info
Howard Drazner President
To view Pharmakon (Biological Product)’s complete executive team members history, request access »

Pharmakon (Biological Product) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Pharmakon (Biological Product)‘s full profile, request access.

Request a free trial

Pharmakon (Biological Product) FAQs

  • Where is Pharmakon (Biological Product) headquartered?

    Pharmakon (Biological Product) is headquartered in Schaumburg, IL.

  • What industry is Pharmakon (Biological Product) in?

    Pharmakon (Biological Product)’s primary industry is Other Healthcare Services.

  • Is Pharmakon (Biological Product) a private or public company?

    Pharmakon (Biological Product) is a Private company.

  • What is Pharmakon (Biological Product)’s current revenue?

    The current revenue for Pharmakon (Biological Product) is 000000.

  • Who are Pharmakon (Biological Product)’s investors?

    Interpace Biosciences has invested in Pharmakon (Biological Product).

  • When was Pharmakon (Biological Product) acquired?

    Pharmakon (Biological Product) was acquired on 31-Dec-2011.

  • Who acquired Pharmakon (Biological Product)?

    Pharmakon (Biological Product) was acquired by Informed Medical Communications.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »